NanoSIRNA

NanosiRNA® COVID-19: specific antiviral treatment Medesis Pharma has a microemulsion

Learn more

NanoManganese

Medesis Pharma is developing a radioprotection drug to treat people irradiated following

Learn more

Viral diseases

Text currently

Learn more

Alzheimer’s disease

Alzheimer’s disease is the most frequent cause of dementia and one of the most

Learn more

Nuclear radioprotection drug

The objective of the radioprotection program is to develop a radiomitigation drug,

Learn more

Cesium decorporation

NU02 Cesium decorporation 137Cs is gamma and beta emitting by-product of uranium

Learn more

AONYS® drug delivery technology

AONYS® is a mix of lipidic components that spontaneously assemble into a water-in-oil

Learn more

Drug to treat neurodegenerative diseases

NanoLithium® (NP03) is a disease-modifying nano dose formulation of lithium citrate

Learn more

Nuclear decorporation drugs – Plutonium decorporation

NU01 Plutonium decorporation Plutonium (Pu) is an alpha emitting radionuclide which

Learn more

Huntington’s disease

Huntington’s Disease (HD) is a fatal autosomal dominant progressive neurodegenerative

Learn more